Fairmount Funds Management LLC's Net Worth

$59.9 Million

Estimate Recalculated Jun 7, 2024 07:14PM EST

Who is Fairmount Funds Management LLC?

Fairmount Funds Management LLC has an estimated net worth of $59.9 Million. This is based on reported shares across multiple companies, which include Apogee Therapeutics, Inc., Viridian Therapeutics, Inc.\DE, Cogent Biosciences, Inc., Spyre Therapeutics, Inc., and Dianthus Therapeutics, Inc. /DE/.

SEC CIK

Fairmount Funds Management LLC's CIK is 0001802528

Past Insider Trading and Trends

2020 was Fairmount Funds Management LLC's most active year for acquiring shares with 12 total transactions. Fairmount Funds Management LLC's most active month to acquire stocks was the month of August. 2023 was Fairmount Funds Management LLC's most active year for disposing of shares, totalling 1 transactions. Fairmount Funds Management LLC's most active month to dispose stocks was the month of December. 2023 saw Fairmount Funds Management LLC paying a total of $60,998,761.21 for 4,416,034 shares, this is the most they've acquired in one year. In 2024 Fairmount Funds Management LLC cashed out on 892,529 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Apogee Therapeutics, Inc. (APGE) Snapshot price: $35.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 5
Form 4
0
2.05M
Mar 28
Form 4
-88.53%
-790.20K
102.33K
Scheduled
Jan 29
Form 4
2.94M
$17.00
$49,999,992.00
2.94M
Jul 13
Form 3
0
0
No matching records found

Spyre Therapeutics, Inc. (AGLE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 14
Form 4
+961.81%
3.64M
4.02M
Apr 25
Form 4
-76.36%
-2.62M
812.08K
Dec 29
Form 4
0
0
Dec 7
Form 4
3.44M
3.44M
Nov 24
Form 3
0
0
No matching records found

Dianthus Therapeutics, Inc. /DE/ (DNTH) Snapshot price: $23.55

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 23
Form 4
0
2.7M
Apr 1
Form 4
+43.26%
834.33K
$12.00
$10,012,008.00
2.76M
Jan 22
Form 4
+1.30%
24.67K
$13.63
$336,252.10
1.93M
Sep 29
Form 4
+1.60%
30K
$13.15
$394,500.00
1.9M
Sep 26
Form 4
+1.63%
30K
$13.20
$396,000.00
1.87M
Sep 19
Form 4
+1.33%
24.25K
$11.20
$271,679.87
1.84M
Sep 11 - Sep 13
Form 3
0
0
No matching records found

Viridian Therapeutics, Inc.\DE (VRDN) Snapshot price: $17.735

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
1.85M
Mar 28
Form 4
+34.92%
476.19K
$21.00
$9,999,990.00
1.84M
Jan 22
Form 4
0
0
Oct 30
Form 4
+45.35%
425.53K
$23.50
$9,999,978.50
1.36M
Aug 17
Form 4
+3,109.50%
909K
$11.00
$9,999,000.00
938.23K
Sep 21
Form 4
0
0
Oct 30
Form 3
0
0
Form 4
526.39K
526.39K
Oct 27
No matching records found

Cogent Biosciences, Inc. (COGT) Snapshot price: $5.875

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
4.73M
Mar 28
Form 4
+35.65%
1.17M
$7.50
$8,749,995.00
4.44M
Feb 16
Form 4
+32.36%
800K
$12.00
$9,600,000.00
3.27M
Jun 9
Form 4
+94.33%
1.2M
$8.25
$9,900,000.00
2.47M
Jun 16
Form 4
0
0
Jul 9
Form 4
6.24M
6.24M
Jul 6
Form 3
0
0
No matching records found